Quality of essential drugs in tropical countries: evaluation of antimalarial drugs in the Brazilian Health System

Abstract

Introduction:The emergence of drug resistance is one of the main problems concerning malaria treatment. The use of counterfeit and/or substandard antimalarial drugs can contribute to the development of parasite resistance. Thus, the aim of this study was to evaluate the quality of antimalarial drugs distributed in Brazil. Methods: Samples containing chloroquine phosphate, mefloquine hydrochloride, primaquine phosphate, and quinine sulfate tablets were delivered to the Rio de Janeiro central storeroom (CENADI), state storerooms (SS), and Basic Health Units (BHUs) in the north region of Brazil -a total of 10 sample sets. After 5 months of storage, the samples were collected, and in vitro quality control analyses according to official and published methods were performed. Results: Inadequate drug storage conditions were found in two SS and in all BHUs evaluated. There were no quality deviations found in the chloroquine samples. The quinine samples exhibited weight variation above the allowed limits. The primaquine samples were found to have packaging deficiency. The release of mefloquine in samples from some regions showed a statistically significant difference when compared with the CENADI samples. Conclusions: It is important to periodically evaluate the quality and storage conditions of essential drugs. The quality deviations found with the primaquine and quinine samples are not related to storage conditions and must be addressed urgently. The decreased mefloquine release from tablets is related to formulation problems or influenced by inadequate storage conditions, prompting further investigation. Even with the mentioned problems, the samples would probably not contribute to resistant parasite selection. Keywords: Malaria. Antimalarial drugs. Brazilian Amazon. Drug storage. Drug stability. Quality control. RESUMOIntrodução: O aparecimento de resistência aos medicamentos é um dos maiores problemas do tratamento da malária. O uso de medicamentos falsos e/ou de má qualidade pode contribuir para o desenvolvimento de resistência no parasita. Este estudo tem por objetivo avaliar a qualidade dos medicamentos antimaláricos distribuídos no Brasil. Métodos: Amostras contendo comprimidos de difosfato de cloroquina, cloridrato de mefloquina, difosfato de primaquina e sulfato de quinina foram enviadas ao almoxarifado central na Cidade do Rio de Janeiro (CENADI), almoxarifados estaduais (SS) e Unidades Básicas de Saúde (UBS) nos estados da região norte do Brasil, totalizando dez amostras. Após cinco meses de armazenamento, as amostras foram coletadas e analisadas segundo métodos oficiais e da literatura. Resultados: Foram encontradas condições inadequadas de armazenamento de medicamentos em duas SS e em todas as UBS avaliadas. Não foram encontrados problemas de qualidade com as amostras de cloroquina. As amostras de quinina apresentaram variação de peso acima dos limites permitidos. Amostras de primaquina foram encontradas com problemas na embalagem. A cedência de mefloquina de comprimidos, em algumas regiões, apres...

Plasmodium vivax malaria relapses at a travel medicine centre in Rio de Janeiro, a non-endemic area in Brazil

“…Studies performed in Brazil indicate that poor quality anti-malarial drugs and inappropriate storage conditions may contribute to the development of parasite resistance [30,31]. In the present study, poor quality primaquine was suspected as a potential cause of relapse after four relapses in a short time, three of them in one patient, after treatment with the same batch of primaquine [32].…”

Factors associated with recurrent Plasmodium vivax malaria in Porto Velho, Rondônia State, Brazil, 2009

“…Recurrence is due to one of the following: (a) therapeutic failure resulting from non-adherence to treatment 3 , resistance of the parasite to the drugs used 4 , poor quality of the medication 5 , or sub-therapeutic doses of the drugs 4 ; (b) reactivation of hypnozoites 2 ; and (c) exposure to new infection by the mosquito vector. Conceptually, recurrent malaria can result from recrudescence, relapse, or reinfection.…”

Physico-Technical Properties of the Granules and Tablets of Micronised Moringa Oleifera Leaf: The Effect of Binders

“…The evaluation of the moisture uptake characteristic of Mo-P and the granules is important because Mo-P which is the active ingredient in the formulation of moringa tablets are known to contain substance(s) with the potential to undergo hydrolysis in the presence of moisture. [14][15][16] The relative low moisture content of the granules could be linked to the intrinsic properties of the bulk material (Mo-P). The bulk material consists largely of pulverized leaf which consists largely of lignin and cellulose.…”